The Effects of Bromelain Supplement in Patients With Ulcerative Colitis

The Effects of Low FODMAP Diets Accompanied With and Without Bromelain Supplement on Quality of Life, Disease Activity Index and Inflammation in Patients With Ulcerative Colitis With and Without Primary Sclerosis Cholangitis

In this study, patients with active mild to moderate UC with or without PSC will be randomized to receive either bromlein or placebo along with low FODMAP diet for 8 weeks.

IBDQ, SCCAIQ, CRP, TAC, TNF-a will be measured before and after the intervention.

Inclusion Criteria:

• active mild to moderate UC
• no other chronic disorders

Exclusion Criteria:

• changed the type and dosage of their medication in the last month
• those who have relapses that required hospitalization and change the type and dosage of medications during the intervention
• patients who do not want to continue the study protocol